Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 86

1.

The effect of mind-body and aerobic exercise on negative symptoms in schizophrenia: A meta-analysis.

Vogel JS, van der Gaag M, Slofstra C, Knegtering H, Bruins J, Castelein S.

Psychiatry Res. 2019 Mar 14. pii: S0165-1781(19)30017-4. doi: 10.1016/j.psychres.2019.03.012. [Epub ahead of print] Review.

PMID:
30879703
2.

[Decision aid for the treatment of psychotic illness: development of TReatment E-AssisT (TREAT)].

Roebroek LO, Bruins J, Knegtering H, Bruggeman R, Delespaul PH, Castelein S.

Tijdschr Psychiatr. 2019;61(2):92-96. Dutch.

3.

[The three-monthly paliperidone palmitate depot in the treatment of schizophrenia].

Spoelstra SK, Bais L, Knegtering H.

Tijdschr Psychiatr. 2018;60(12):827-833. Review. Dutch.

4.

[Sexual dysfunction as a side effect of medication].

van Berkel A, Seldenrijk A, Knegtering H, Bakker PR, Ruhé HG, Kramers C.

Ned Tijdschr Geneeskd. 2018 Sep 5;162. pii: D2749. Dutch. No abstract available.

PMID:
30209903
5.

Effects of bilateral prefrontal rTMS on brain activation during social-emotional evaluation in schizophrenia: A double-blind, randomized, exploratory study.

Liemburg EJ, Dlabac-De Lange JJ, Bais L, Knegtering H, Aleman A.

Schizophr Res. 2018 Dec;202:210-211. doi: 10.1016/j.schres.2018.06.051. Epub 2018 Jun 27.

PMID:
29954702
6.

The development and evaluation of a computerized decision aid for the treatment of psychotic disorders.

Tasma M, Roebroek LO, Liemburg EJ, Knegtering H, Delespaul PA, Boonstra A, Swart M, Castelein S.

BMC Psychiatry. 2018 Jun 1;18(1):163. doi: 10.1186/s12888-018-1750-7.

7.

Relation of inflammatory markers with symptoms of psychotic disorders: a large cohort study.

Liemburg EJ, Nolte IM; PHAMOUS investigators, Klein HC, Knegtering H.

Prog Neuropsychopharmacol Biol Psychiatry. 2018 Aug 30;86:89-94. doi: 10.1016/j.pnpbp.2018.04.006. Epub 2018 May 18.

PMID:
29778547
8.

Moderate effects of noninvasive brain stimulation of the frontal cortex for improving negative symptoms in schizophrenia: Meta-analysis of controlled trials.

Aleman A, Enriquez-Geppert S, Knegtering H, Dlabac-de Lange JJ.

Neurosci Biobehav Rev. 2018 Jun;89:111-118. doi: 10.1016/j.neubiorev.2018.02.009. Epub 2018 Feb 19. Review.

9.

Towards a comprehensive routine outcome monitoring program for people with psychotic disorders: The Pharmacotherapy Monitoring and Outcome Survey (PHAMOUS).

Bartels-Velthuis AA, Visser E, Arends J, Pijnenborg GHM, Wunderink L, Jörg F, Veling W, Liemburg EJ, Castelein S, Knegtering H, Bruggeman R.

Schizophr Res. 2018 Jan 26. pii: S0920-9964(18)30036-7. doi: 10.1016/j.schres.2018.01.016. [Epub ahead of print]

PMID:
29395613
10.

Natural Medicines for Psychotic Disorders: A Systematic Review.

Hoenders HJR, Bartels-Velthuis AA, Vollbehr NK, Bruggeman R, Knegtering H, de Jong JTVM.

J Nerv Ment Dis. 2018 Feb;206(2):81-101. doi: 10.1097/NMD.0000000000000782.

11.
12.

[Non-invasive brain stimulation in schizophrenia: hallucinations and negative symptoms].

Aleman A, Brummelman J, Dlabac-de Lange JJ, Koops S, Knegtering H, Neggers SFW, Sommer IE.

Tijdschr Psychiatr. 2017;59(10):612-616. Dutch.

13.

Neural basis of self-initiative in relation to apathy in a student sample.

Kos C, Klaasen NG, Marsman JC, Opmeer EM, Knegtering H, Aleman A, van Tol MJ.

Sci Rep. 2017 Jun 12;7(1):3264. doi: 10.1038/s41598-017-03564-5.

14.

Effects of aripiprazole versus risperidone on brain activation during planning and social-emotional evaluation in schizophrenia: A single-blind randomized exploratory study.

Liemburg EJ, van Es F, Knegtering H, Aleman A.

Prog Neuropsychopharmacol Biol Psychiatry. 2017 Oct 3;79(Pt B):112-119. doi: 10.1016/j.pnpbp.2017.05.022. Epub 2017 May 27.

PMID:
28558941
15.

Glutamate in dorsolateral prefrontal cortex and auditory verbal hallucinations in patients with schizophrenia: A 1H MRS study.

Ćurčić-Blake B, Bais L, Sibeijn-Kuiper A, Pijnenborg HM, Knegtering H, Liemburg E, Aleman A.

Prog Neuropsychopharmacol Biol Psychiatry. 2017 Aug 1;78:132-139. doi: 10.1016/j.pnpbp.2017.05.020. Epub 2017 May 22.

PMID:
28546056
16.

Effects of low frequency rTMS treatment on brain networks for inner speech in patients with schizophrenia and auditory verbal hallucinations.

Bais L, Liemburg E, Vercammen A, Bruggeman R, Knegtering H, Aleman A.

Prog Neuropsychopharmacol Biol Psychiatry. 2017 Aug 1;78:105-113. doi: 10.1016/j.pnpbp.2017.04.017. Epub 2017 Apr 22.

PMID:
28442422
17.

[Clinical application of ROM in psychosis].

Tasma M, Swart M, Wolters G, Liemburg EJ, Bruggemans R, Knegtering H, Castelein S.

Ned Tijdschr Geneeskd. 2017;161:D845. Dutch.

PMID:
28325158
18.

Exploring the use of Routine Outcome Monitoring in the treatment of patients with a psychotic disorder.

Tasma M, Liemburg EJ, Knegtering H, Delespaul PAEG, Boonstra A, Castelein S.

Eur Psychiatry. 2017 May;42:89-94. doi: 10.1016/j.eurpsy.2016.12.008. Epub 2016 Dec 28.

PMID:
28314165
19.

[Mindfulness training for psychiatrists in residency: a pilot study].

Hoenders HJ, Booij SH, Knegtering H, van den Brink H.

Tijdschr Psychiatr. 2016;58(11):809-813. Dutch.

20.

[A study of cost-effectiveness of treating serious mental illness: challenges and solutions].

Lokkerbol J, Nuijen J, Evers S, Knegtering H, Delespaul P, Kroon H, Bruggeman R.

Tijdschr Psychiatr. 2016;58(10):700-705. Dutch.

Supplemental Content

Loading ...
Support Center